Oncternal Therapeutics (ONCT) Revenue (2019 - 2024)
Oncternal Therapeutics (ONCT) revenue from Jun 30, 2019 to Sep 30, 2024. The TTM Oncternal Therapeutics (ONCT) revenue is $2.16M. You can adjust inflation or export chart.
Annual Revenue
Quarterly Revenue
Oncternal Therapeutics (ONCT) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +227.27% |
| 3 Years TTM | -26.09% |
| 5 Years TTM | +12.29% |
| All Time TTM | -3.20% |
Annual Revenue change of Oncternal Therapeutics (ONCT)
| Year | Revenue | Change |
|---|---|---|
| 2024 | $1.86M | +135.44% |
| 2023 | $790K | -46.98% |
| 2022 | $1.49M | -65.51% |
| 2021 | $4.32M | +27.81% |
| 2020 | $3.38M | +39.67% |
| 2019 | $2.42M | N/A |